Search Results 1-10 of 11546 for Ibrance

  1. Palbociclib (oral route) - Side effects & dosage - Mayo Clinic

    Ibrance. Back to top. Description. Palbociclib is used to treat hormone receptor (HR)-positive, HER-2 negative advanced or metastatic (cancer that has spread) ...

  2. Breast Cancer: PROMISE Study - Center for Individualized Medicine - Mayo Clinic Research

    Endocrine resistance is common in patients with breast cancer, and while the drug palbociclib (Ibrance) in combination with endocrine therapy has provided ...

  3. Hormone therapy for breast cancer - Mayo Clinic

    Palbociclib (Ibrance). Ribociclib (Kisqali). Everolimus (Afinitor). Results. You'll meet with your cancer doctor, called an oncologist, regularly for follow ...

  4. Drugs and Supplements that Start with I - Mayo Clinic

    Ibrance. Also known as. Palbociclib (oral route) · Ibrexafungerp (oral route) · Ibritumomab (intravenous route) · Ibrutinib (oral route). Ibsrela. Also known as.

  5. Clinical studies - Center for Individualized Medicine - Mayo Clinic Research

    ... (Ibrance) and endocrine therapy. Other aims are to discover microbiome-based biomarkers of treatment response, to evaluate drug response phenotypes using ...

  6. Fulvestrant (intramuscular route) - Mayo Clinic

    Fulvestrant injection is used to treat hormone-receptor (HR) positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in ...

  7. Pharmacogenomics Program - Center for Individualized Medicine - Mayo Clinic Research

    Endocrine resistance is common in patients with breast cancer, and while the drug palbociclib (Ibrance) in combination with endocrine therapy has provided ...

  8. Cancer Treatment! Clinical Trials - Mayo Clinic Research

    The purpose of this study is to estimate the best response of enfortumab vedotin treatment for patients with metastatic squamous cell carcinoma of the penis ( ...

  9. Estrogen Receptor Positive Breast Cancer Clinical Trials - Mayo Clinic Research

    Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes. It is not yet known whether letrozole is more ...

  10. Recurrent Breast Cancer Clinical Trials - Mayo Clinic Research

    The purpose of this study is to offer pre-approval drug access of iniparib combined with gemcitabine and carboplatin, in order to provide potential clinical ...